What is the market capitalization of Abivax SA?

Abivax SA (ABVX) has a market capitalization of approximately 7,184,462,330 USD.

How many ETFs hold ABVX?

ABVX is held by 5 ETFs tracked on Investir en Bourse.

Where can I buy ABVX in Canada?

ABVX can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

ABVX

Abivax SA

Abivax SA (ABVX) is a France company in the healthcare sector, listed on NASDAQ. Market capitalization of 7.2 billion USD (mid-cap).

Details

Price90.15 USD

Market cap7.18 G USD

Payout ratio0.00%

ROE-157.07%

Debt / Equity7.96%

SectorHealthcare

Websiteabivax.com

Updated 1h ago

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.